Sarcopenic obesity in type 2 diabetes: An underrecognized clinical challenge

Unknown · 2026

Read Sarcopenic obesity in type 2 diabetes: An underrecognized clinical challenge by Unknown (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13098427.txt.

Description

Muscle loss paired with fat gain is a quiet threat inside type 2 diabetes care. A 2026 letter weighs a Thai study that found this paired state in 16.4 percent of patients. Broader Asian counts run near 26 percent, the letter notes.

The gap likely stems from shifting rules for naming both states. The Thai team's fat-based cutoffs earn praise as the sharper choice. Age and calf size flagged risk, while grip strength guarded against it. The cross-sectional design cannot prove cause, the writers warn. One urban center also limits how far the numbers travel. Shared definitions would firm up the field.

Catalog record

CREATORUnknown
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13098427

Browse the full library · About the Tower of Babel